The final report of a phase I/II study of panobinostat in combination with ICE (ifosfamide, carboplatin and etoposide) in patients (pts) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL) Meeting Abstract

  

Authors:	Hu, B.; Younes, A.; Claret, L.; Feng, L.; Westin, J. R.; Fowler, N.; Neelapu, S.; Hagemeister, F. B.; Rodriguez, M. A.; Samaniego, F.; Fayad, L. E.; Nastoupil, L. J.; Copeland, A. R.; Fanale, M. A.; Oki, Y.
Abstract Title:	The final report of a phase I/II study of panobinostat in combination with ICE (ifosfamide, carboplatin and etoposide) in patients (pts) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
Meeting Title:	58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	128
Issue:	22
Meeting Dates:	2016 Dec 3-6
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2016-12-02
Language:	English
ACCESSION:	WOS:000394452308030
PROVIDER:	wos
DOI:	10.1182/blood.V128.22.1833.1833
Notes:	Meeting Abstract: 1833 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/127244